Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Request a FREE Sample of our FcRn Binding Kit!
Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| GP1-H51H3 | HIV-1 (HXB2) | HIV-1 (HXB2) GP41 Pre-hairpin intermediate Protein, His Tag |  |
|
|
Monoclonal Anti-HIV-1 GP41 Antibody, Human IgG1 (2F5) captured on Protein A Chip can bind HIV-1 (HXB2) GP41 Pre-hairpin intermediate Protein, His Tag (Cat. No. GP1-H51H3) with an affinity constant of 0.468 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Albuvirtide | FB-006M | Approved | Frontier Biotechnologies Inc | 艾可宁 | Mainland China | HIV Infections | Frontier Biotechnologies Inc | 2018-05-23 | Acquired Immunodeficiency Syndrome; HIV Infections | Details |
| Enfuvirtide | T-20; R-698; DP-178 | Approved | F. Hoffmann-La Roche Ltd | Fuzeon | United States | HIV Infections | F. Hoffmann-La Roche Ltd | 2003-03-13 | HIV Infections; Acquired Immunodeficiency Syndrome; HIV Seropositivity | Details |
| Albuvirtide | FB-006M | Approved | Frontier Biotechnologies Inc | 艾可宁 | Mainland China | HIV Infections | Frontier Biotechnologies Inc | 2018-05-23 | Acquired Immunodeficiency Syndrome; HIV Infections | Details |
| Enfuvirtide | T-20; R-698; DP-178 | Approved | F. Hoffmann-La Roche Ltd | Fuzeon | United States | HIV Infections | F. Hoffmann-La Roche Ltd | 2003-03-13 | HIV Infections; Acquired Immunodeficiency Syndrome; HIV Seropositivity | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Sifuvirtide | FS-0101; SFT | Phase 2 Clinical | Tianjin Fusogen Pharmaceuticals Inc | HIV Infections; Acquired Immunodeficiency Syndrome | Details |
| PGT-121 | PGT-121 | Phase 2 Clinical | International Aids Vaccine Initiative, Theraclone Sciences Inc, The Scripps Research Institute Inc, The Ragon Institute Of Mgh, Mit And Harvard | HIV Infections; Acquired Immunodeficiency Syndrome; Retroviridae Infections; Sexually Transmitted Diseases, Viral; HIV Seropositivity | Details |
| MPER-656 liposome vaccine | MPER-656 | Phase 1 Clinical | National Institute Of Allergy And Infectious Diseases (Niaid) | HIV Infections | Details |
| Microbicide monoclonal antibody triple combination (Polymun Scientific Immunobiologische Forschung) | Phase 1 Clinical | Polymun Scientific Gmbh | HIV Infections | Details | |
| Elipovimab | GS-9722 | Phase 1 Clinical | HIV Infections | Details | |
| CPT-31 | CPT-31; CPT31-LA | Phase 1 Clinical | Navigen | Purpura, Thrombocytopenic, Idiopathic; HIV Infections | Details |
| FB-1002(Frontier Biotechnologies) | FB-1002(前沿生物) | Phase 1 Clinical | Frontier Biotechnologies Inc, Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | Coronavirus Disease 2019 (COVID-19) | Details |
| Sifuvirtide | FS-0101; SFT | Phase 2 Clinical | Tianjin Fusogen Pharmaceuticals Inc | HIV Infections; Acquired Immunodeficiency Syndrome | Details |
| PGT-121 | PGT-121 | Phase 2 Clinical | International Aids Vaccine Initiative, Theraclone Sciences Inc, The Scripps Research Institute Inc, The Ragon Institute Of Mgh, Mit And Harvard | HIV Infections; Acquired Immunodeficiency Syndrome; Retroviridae Infections; Sexually Transmitted Diseases, Viral; HIV Seropositivity | Details |
| MPER-656 liposome vaccine | MPER-656 | Phase 1 Clinical | National Institute Of Allergy And Infectious Diseases (Niaid) | HIV Infections | Details |
| Microbicide monoclonal antibody triple combination (Polymun Scientific Immunobiologische Forschung) | Phase 1 Clinical | Polymun Scientific Gmbh | HIV Infections | Details | |
| Elipovimab | GS-9722 | Phase 1 Clinical | HIV Infections | Details | |
| CPT-31 | CPT-31; CPT31-LA | Phase 1 Clinical | Navigen | Purpura, Thrombocytopenic, Idiopathic; HIV Infections | Details |
| FB-1002(Frontier Biotechnologies) | FB-1002(前沿生物) | Phase 1 Clinical | Frontier Biotechnologies Inc, Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | Coronavirus Disease 2019 (COVID-19) | Details |
This web search service is supported by Google Inc.
A-Z
